In addition, the sustained increasing PKCδ of human fibroblasts of DM hindered wound healing and insulin signaling was observed, thereby PKCδ inhibition may be a novel approach for treating diabetic wounds [49]. The gene discussed is PRKCD; the disease is diabetes mellitus.